Stock Track | Labcorp Soars 9.80% in Pre-market on Strong Q1 Earnings Beat and Raised 2026 Guidance

Stock Track

04/30

Labcorp Holdings Inc's stock surged 9.80% in pre-market trading following the release of its first-quarter 2026 financial results that exceeded analyst expectations and an upward revision of its full-year outlook.

The company reported adjusted earnings per share of $4.25 for Q1 2026, beating consensus estimates of approximately $4.09 to $4.11 and representing a 10.6% increase from the same period last year. Revenue rose 5.8% year-over-year to $3.54 billion, also surpassing analyst forecasts of around $3.50 to $3.51 billion.

Labcorp raised its full-year 2026 guidance, now expecting adjusted EPS in the range of $17.70 to $18.35 and revenue between $14.65 billion and $14.80 billion. The company cited organic growth, continued momentum across its Diagnostics and Central Laboratory businesses, and strategic initiatives including expansion in specialty diagnostics and new collaborations as drivers of its strong performance.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1185853360"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1185853360\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1185853360?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-30 19:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1185853360","market":"hk","top_or_hot":-1,"title":"Stock Track | Labcorp Soars 9.80% in Pre-market on Strong Q1 Earnings Beat and Raised 2026 Guidance","media":"Stock Track","content":"<p>Labcorp Holdings Inc's stock surged 9.80% in pre-market trading following the release of its first-quarter 2026 financial results that exceeded analyst expectations and an upward revision of its full-year outlook.</p><p>The company reported adjusted earnings per share of $4.25 for Q1 2026, beating consensus estimates of approximately $4.09 to $4.11 and representing a 10.6% increase from the same period last year. Revenue rose 5.8% year-over-year to $3.54 billion, also surpassing analyst forecasts of around $3.50 to $3.51 billion.</p><p>Labcorp raised its full-year 2026 guidance, now expecting adjusted EPS in the range of $17.70 to $18.35 and revenue between $14.65 billion and $14.80 billion. The company cited organic growth, continued momentum across its Diagnostics and Central Laboratory businesses, and strategic initiatives including expansion in specialty diagnostics and new collaborations as drivers of its strong performance.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Labcorp Soars 9.80% in Pre-market on Strong Q1 Earnings Beat and Raised 2026 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Labcorp Soars 9.80% in Pre-market on Strong Q1 Earnings Beat and Raised 2026 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-30 19:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Labcorp Holdings Inc's stock surged 9.80% in pre-market trading following the release of its first-quarter 2026 financial results that exceeded analyst expectations and an upward revision of its full-year outlook.</p><p>The company reported adjusted earnings per share of $4.25 for Q1 2026, beating consensus estimates of approximately $4.09 to $4.11 and representing a 10.6% increase from the same period last year. Revenue rose 5.8% year-over-year to $3.54 billion, also surpassing analyst forecasts of around $3.50 to $3.51 billion.</p><p>Labcorp raised its full-year 2026 guidance, now expecting adjusted EPS in the range of $17.70 to $18.35 and revenue between $14.65 billion and $14.80 billion. The company cited organic growth, continued momentum across its Diagnostics and Central Laboratory businesses, and strategic initiatives including expansion in specialty diagnostics and new collaborations as drivers of its strong performance.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LH","symbol_name":"徕博科","start_time":0,"source_url":"","article_id":"1185853360","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1185853360","pubTimestamp":1777548779,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Labcorp Holdings Inc's stock surged 9.80% in pre-market trading following the release of its first-quarter 2026 financial results that exceeded analyst expectations and an upward revision of its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LH":"徕博科"},"translate_title":"股票追踪|Labcorp盘前飙升9.80%，第一季度盈利强劲，并上调2026年指引","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LH":1},"content_text":"Labcorp Holdings Inc's stock surged 9.80% in pre-market trading following the release of its first-quarter 2026 financial results that exceeded analyst expectations and an upward revision of its full-year outlook.The company reported adjusted earnings per share of $4.25 for Q1 2026, beating consensus estimates of approximately $4.09 to $4.11 and representing a 10.6% increase from the same period last year. Revenue rose 5.8% year-over-year to $3.54 billion, also surpassing analyst forecasts of around $3.50 to $3.51 billion.Labcorp raised its full-year 2026 guidance, now expecting adjusted EPS in the range of $17.70 to $18.35 and revenue between $14.65 billion and $14.80 billion. The company cited organic growth, continued momentum across its Diagnostics and Central Laboratory businesses, and strategic initiatives including expansion in specialty diagnostics and new collaborations as drivers of its strong performance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}